Navigation Links
Hospira Reports Third-Quarter 2007 Results
Date:11/8/2007

---------- ----------

Net Cash Provided by Operating Activities 354,485 331,865

---------- ----------

Cash Flow From Investing Activities:

Capital expenditures (including instruments

placed with or leased to customers) (128,674) (183,632)

Acquisition of Mayne Pharma, net of

cash acquired (1,961,285) -

Settlements of foreign currency contracts (55,701) -

Proceeds from dispositions of product rights 13,771 -

Other, net (1,263) 1,845

---------- ----------

Net Cash Used in Investing Activities (2,133,152) (181,787)

---------- ----------

Cash Flow From Financing Activities:

Issuance of long-term debt, net of

fees paid 3,336,198 -

Repayment of long-term debt (1,700,124) (111)

Other borrowings, net (343) 1,955

Payment to Abbott Laboratories for

international assets - (124,251)

Common stock repurchased - (299,766)

Excess tax benefit from stock-based

compensation arrangements 865 3,373

Proceeds from stock options exercised 40,464 39,576

---------- ----------

Net Cash Provided by (Used in)

Financing Activities 1,677,060 (379,224)

---------- -------
'/>"/>

SOURCE Hospira, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26

Related medicine news :

1. Hospira to Present at the Bear Stearns 20th Annual Healthcare Conference on September 11
2. Hospira to Present at the Credit Suisse Phoenix Health Care Conference on November 13
3. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
4. Haemacure Reports Third Quarter 2007 Results
5. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
6. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
7. MDS Reports Third Quarter 2007 Results
8. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
9. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
10. NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results
11. Blue Cross and Blue Shield of Florida Reports Eighteenth Consecutive Year of Positive Performance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... 2015 Nitrosigine®, a patented complex of ... sports nutrition products, is hosting the Nitrosigine Pump Challenge ... Terrace Ballroom at The Arnold Sports Festival in Columbus, ... to March 8, 2015. , Nitrosigine is a ... Dietary Ingredient notification status; now affirmed as GRAS.^ It ...
(Date:3/4/2015)... March 04, 2015 The report “Vasculitis ... the therapeutic development for Vasculitis. Vasculitis is a disease ... cause of vasculitis diseases is not known. Vasculitis can ... range of symptoms. Symptoms can include fever, weight loss, ... a pulse in a limb. Vasculitis is treatable, but ...
(Date:3/4/2015)... The week of March 2nd - 8th ... Awareness Day being recognized on March 13th, the aim ... risks associated with sleep related illnesses, costing the United ... of America have turned to social media with an ... virally inspire conversation regarding the disease. , The ...
(Date:3/4/2015)... March 04, 2015 Follow us ... public health issue worldwide. The rising prevalence of high ... social burden in both developed and developing countries. By ... to rise to 1.5 billion, equating to approximately 30% ... patients are forecast to come from the developing countries. ...
(Date:3/4/2015)... March 04, 2015 Bird B Gone, ... and residential applications now offers its popular plastic (polycarbonate) ... humane, highly efficient bird deterrent is ready-to-use ... the color and décor of the building or structure ... red, white, crystal clear, light grey, brown, black and ...
Breaking Medicine News(10 mins):Health News:Nitrosigine® Challenges Fitness Enthusiasts at The Arnold to Get Pumped 2Health News:Nitrosigine® Challenges Fitness Enthusiasts at The Arnold to Get Pumped 3Health News:Vasculitis Therapeutics Pipeline H1 2015 Review Report Available at RnRMarketResearch.com 2Health News:Vasculitis Therapeutics Pipeline H1 2015 Review Report Available at RnRMarketResearch.com 3Health News:Vasculitis Therapeutics Pipeline H1 2015 Review Report Available at RnRMarketResearch.com 4Health News:Innovative Sleep Apnea Procedure Could Save US Healthcare System Billions 2Health News:Innovative Sleep Apnea Procedure Could Save US Healthcare System Billions 3Health News:Innovative Sleep Apnea Procedure Could Save US Healthcare System Billions 4Health News:Aging Population Drives Demand for Blood Pressure Monitoring & Measurement Instruments, According to a New Report by Global Industry Analysts, Inc. 2Health News:Aging Population Drives Demand for Blood Pressure Monitoring & Measurement Instruments, According to a New Report by Global Industry Analysts, Inc. 3Health News:Aging Population Drives Demand for Blood Pressure Monitoring & Measurement Instruments, According to a New Report by Global Industry Analysts, Inc. 4Health News:Plastic Bird Spikes Now Come in 7 Colors to Blend in With Their Surroundings 2
... Your ability to listen to a phone message in ... other earand comprehend what both are sayingis an ... say researchers of the National Institute on Deafness and ... of Health. ,The finding, published in the ...
... Believe it or not, Kapila, an impregnated cow of Sarnagat ... the age of two without ever getting crossed with a ... years now. ,According to the cows owner Sardar ... two-years-old and that too without ever getting pregnant. ...
... a new review of studies,School-based sexual abuse prevention programs ... increase self-protective behaviors. ,However, the programs have ... fearful of strangers, the review cautions. ,,It was ... found in the review, but we were pleased that ...
... dig into that apple or lentils, for a new study ... slowly once they have been consumed helps dieters lose more ... ,Foods that release sugars rapidly are said to ... slowly have a low glycaemic index, and Cochrane researchers led ...
... The Balehonnur-based Central Coffee Research Institute (CCRI) has said that ... market in December 2007 . ,After 21 years ... on December 15. The yet-to-be named hybrid, hi-yielding arabica variety ... less resistant to the widely prevalent white stem borer. ...
... universal influenza vaccine that has been pioneered by researchers ... the first time on humans by the British-American biotech ... intended to provide protection against all A strains of ... ,In the 1990s, VIB researchers connected ...
Cached Medicine News:Health News:Genes Influence the Ability to Listen Two Things at a Time 2Health News:Genes Influence the Ability to Listen Two Things at a Time 3Health News:School-based Sexual Abuse Prevention Programs 2Health News:School-based Sexual Abuse Prevention Programs 3Health News:Apples and Lentils Could Help You to Shed Off Those Extra Pounds! 2Health News:Human Trial for Universal Influenza Vaccine Underway 2
(Date:3/4/2015)... , Deutschland, 4. März 2015 /PRNewswire/ ... Anbieter von medizinischen Bildmanagementlösungen für Unternehmen, baut ... von Randolph Sternberg zum Director of Sales ... of Operations weiter aus. Logo ... Randolph Sternberg ist für den Verkauf ...
(Date:3/4/2015)... 4, 2015 Oramed Pharmaceuticals Inc. ... clinical-stage pharmaceutical company focused on the development of oral ... participate in the upcoming 27 th Annual ROTH ... Dana Point, CA.  Dr. Michael Berelowitz ... will present a corporate overview on March 10, 2015. ...
(Date:3/4/2015)... 2015 Perrigo Company plc (NYSE: PRGO ... Joseph C. Papa will present at the 2015 ... 11, 2015 at the Loews Miami Beach Hotel in ... presentation webcast at http://perrigo.investorroom.com/events-webcasts . From its ... Perrigo Company plc, headquartered in Ireland , ...
Breaking Medicine Technology:TeraRecon baut seine Präsenz in EMEA aus 2TeraRecon baut seine Präsenz in EMEA aus 3Oramed to Present at the ROTH Conference 2Oramed to Present at the ROTH Conference 3Perrigo Company To Present At The 2015 Barclays Global Healthcare Conference 2
... /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NASDAQ: SVA ), ... its unaudited second quarter financial results for the period ended ... Highlights Sales increased 52.5% year-over-year to $15.7 ... shareholder reached $1.32 million and EPS was $0.02 per share. ...
... Corporation (NYSE: SHP ) ("ShangPharma" or the ... development outsourcing company, today announced that its Board of ... expects to use cash and internally generated funds to ... The board has authorized ShangPharma to buy up ...
Cached Medicine Technology:Sinovac Reports Unaudited Second Quarter 2011 Financial Results 2Sinovac Reports Unaudited Second Quarter 2011 Financial Results 3Sinovac Reports Unaudited Second Quarter 2011 Financial Results 4Sinovac Reports Unaudited Second Quarter 2011 Financial Results 5Sinovac Reports Unaudited Second Quarter 2011 Financial Results 6Sinovac Reports Unaudited Second Quarter 2011 Financial Results 7Sinovac Reports Unaudited Second Quarter 2011 Financial Results 8Sinovac Reports Unaudited Second Quarter 2011 Financial Results 9Sinovac Reports Unaudited Second Quarter 2011 Financial Results 10Sinovac Reports Unaudited Second Quarter 2011 Financial Results 11Sinovac Reports Unaudited Second Quarter 2011 Financial Results 12Sinovac Reports Unaudited Second Quarter 2011 Financial Results 13Sinovac Reports Unaudited Second Quarter 2011 Financial Results 14ShangPharma Announces Up to $10 Million Share Repurchase Program 2
... is a reagent and probe system used ... high throughput plate based system is a ... a unique approach for RNA detection and ... branched DNA (bDNA) technology. Branched DNA allows ...
QC 123 is an assayed quality control material for blood gas instrumentation. It is available in three (3) levels for monitoring analyzer performance at varying points within the clinical range....
For the qualitative detection of Wuchereria bancrofti antigen in whole blood, serum and plasma specimens...
For the qualitative detection of Hepatitis B surface Antigen (HBsAG) in human serum, plasma and whole blood specimens...
Medicine Products: